Schedule 13D ownership disclosure

X4 Pharmaceuticals Inc

Common Stock, par value $0.001 per share · CUSIP: 98420X202

Event date: 2025-08-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Coastlands Capital LPReported CIK 0002068530

    Shares: 2,479,645.00 · Class: 9.99%

  • Coastlands Capital Partners LPReported CIK 0002062655

    Shares: 2,479,645.00 · Class: 9.99%

  • Coastlands Capital GP LLC

    Shares: 2,479,645.00 · Class: 9.99%

  • Coastlands Capital LLCReported CIK 0001508612

    Shares: 2,479,645.00 · Class: 9.99%

  • Matthew D. PerryReported CIK 0001454337

    Shares: 2,479,645.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-079821
Form type
SCHEDULE 13D
Filer
Coastlands Capital LP
CIK
CIK 2068530
Filed
Aug 18, 2025
Reporting period
Aug 11, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub